par Vermijlen, David ;Froelich, C J;Luo, D;Suarez Gonzalez, Nathalie ;Robaye, Bernard ;Wisse, E
Référence Cancer immunology and immunotherapy, 50, 4, page (212-217)
Publication Publié, 2001-06
Référence Cancer immunology and immunotherapy, 50, 4, page (212-217)
Publication Publié, 2001-06
Article révisé par les pairs
Titre: |
|
Auteur: | Vermijlen, David; Froelich, C J; Luo, D; Suarez Gonzalez, Nathalie; Robaye, Bernard; Wisse, E |
Informations sur la publication: | Cancer immunology and immunotherapy, 50, 4, page (212-217) |
Statut de publication: | Publié, 2001-06 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Apoptosis -- drug effects |
Benzimidazoles -- diagnostic use | |
Caspase 3 | |
Caspases -- metabolism | |
Colonic Neoplasms -- metabolism | |
Colonic Neoplasms -- pathology | |
DNA, Neoplasm -- analysis | |
Drug Resistance, Neoplasm | |
Fas Ligand Protein | |
Granzymes | |
Humans | |
Membrane Glycoproteins -- metabolism | |
Membrane Glycoproteins -- pharmacology | |
Perforin | |
Pore Forming Cytotoxic Proteins | |
Propidium -- diagnostic use | |
Serine Endopeptidases -- pharmacology | |
Tumor Cells, Cultured -- drug effects | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0340-7004 |
info:doi/10.1007/s002620100191 | |
info:scp/0034917198 | |
info:pmid/11459173 |